General MedicationsINTRAMUSCULAR, INTRAVENOUSGeneric

LEUCOVORIN CALCIUM

Standard Dose

EQ 500MG BASE/50ML (EQ 10MG BASE/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview LEUCOVORIN CALCIUM is listed in Drugs@FDA under application 210917 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LEUCOVORIN CALCIUM Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - EQ 500MG BASE/50ML (EQ 10MG BASE/ML) Sponsor INGENUS PHARMS LLC Submission history Latest submission status date: 2018-11-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEUCOVORIN CALCIUM is listed in Drugs@FDA under application 210917 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEUCOVORIN CALCIUM Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - EQ 500MG BASE/50ML (EQ 10MG BASE/ML) Sponsor INGENUS PHARMS LLC Submission history Latest submission status date: 2018-11-23 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.